Using cerebrospinal fluid nanopore sequencing assay to diagnose tuberculous meningitis: a retrospective cohort study in China
- PMID: 38862231
- PMCID: PMC11168130
- DOI: 10.1136/bmjopen-2023-080904
Using cerebrospinal fluid nanopore sequencing assay to diagnose tuberculous meningitis: a retrospective cohort study in China
Abstract
Objective: This study aimed to evaluate the efficiency of nanopore sequencing for the early diagnosis of tuberculous meningitis (TBM) using cerebrospinal fluid and compared it with acid-fast bacilli (AFB) smear, mycobacterial growth indicator tube culture and Xpert Mycobacterium tuberculosis (MTB)/rifampicin (RIF).
Design: Single-centre retrospective study.
Setting: The Tuberculosis Diagnosis and Treatment Center of Zhejiang Chinese and Western Medicine Integrated Hospital.
Participants: We enrolled 64 adult patients with presumptive TBM admitted to our hospital from August 2021 to August 2023.
Methods: We calculated the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of AFB smear, culture, Xpert MTB/RIF and nanopore sequencing to evaluate their diagnostic efficacy compared with a composite reference standard for TBM.
Results: Among these 64 patients, all tested negative for TBM by AFB smear. The sensitivity, specificity, PPV and NPV were 11.11%, 100%, 100% and 32.2% for culture, 13.33%, 100%, 100% and 2.76% for Xpert MTB/RIF, and 77.78%, 100%, 100% and 65.52% for nanopore sequencing, respectively.
Conclusion: The diagnostic accuracy of the nanopore sequencing test was significantly higher than that of conventional testing methods used to detect TBM.
Keywords: Diagnostic microbiology; Neurology; Tuberculosis.
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
Diagnostic value of nanopore sequencing of cerebrospinal fluid samples in tuberculous meningitis.Diagn Microbiol Infect Dis. 2025 Feb;111(2):116593. doi: 10.1016/j.diagmicrobio.2024.116593. Epub 2024 Nov 12. Diagn Microbiol Infect Dis. 2025. PMID: 39561665
-
Comparative diagnostic utility of metagenomic next-generation sequencing, GeneXpert, modified Ziehl-Neelsen staining, and culture using cerebrospinal fluid for tuberculous meningitis: A multi-center, retrospective study in China.J Clin Lab Anal. 2022 Apr;36(4):e24307. doi: 10.1002/jcla.24307. Epub 2022 Feb 24. J Clin Lab Anal. 2022. PMID: 35202495 Free PMC article.
-
Performance of Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis in children using cerebrospinal fluid.Sci Rep. 2025 Apr 16;15(1):13060. doi: 10.1038/s41598-025-97664-2. Sci Rep. 2025. PMID: 40240519 Free PMC article.
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013359. doi: 10.1002/14651858.CD013359.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Sep 6;9:CD013359. doi: 10.1002/14651858.CD013359.pub3. PMID: 32853411 Free PMC article. Updated.
-
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD012768. doi: 10.1002/14651858.CD012768.pub3. Cochrane Database Syst Rev. 2021. PMID: 33448348 Free PMC article.
Cited by
-
Epidemiology, Pathogenesis, Clinical Manifestations, and Management Strategies of Tuberculous Meningitis.Arch Intern Med Res. 2025;8(1):48-58. doi: 10.26502/aimr.0195. Epub 2025 Feb 10. Arch Intern Med Res. 2025. PMID: 40061519 Free PMC article.
-
Nanopore sequencing for precise detection of Mycobacterium tuberculosis and drug resistance: a retrospective multicenter study in China.J Clin Microbiol. 2025 Apr 9;63(4):e0181324. doi: 10.1128/jcm.01813-24. Epub 2025 Mar 19. J Clin Microbiol. 2025. PMID: 40105344 Free PMC article.
-
Nanopore-targeted sequencing (NTS) for intracranial tuberculosis: a promising and reliable approach.Ann Clin Microbiol Antimicrob. 2024 Oct 9;23(1):89. doi: 10.1186/s12941-024-00751-x. Ann Clin Microbiol Antimicrob. 2024. PMID: 39385187 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources